David Dean

David Dean is responsible for all corporate development activities.

David brings over 20 years of business development and company analysis experience. Most recently he was Chief Business Development Officer of Correvio where he identified opportunities, analyzed and valued each, negotiated and then wrote multiple drug license agreements that grew the Company’s product portfolio, revenues and outlook for the future. Prior to that, he was Director and Research Analyst at the largest independent investment bank in Canada where he identified healthcare investment opportunities and played a central role in managing each relationship.

He is experienced in identifying, negotiating and executing multiple in and out-licensing transactions as well as significant M&A transactions, acquisitions and divestments.

David holds a Master of Business Administration in finance from Queen’s University and Master of Science in physiology from the Department of Medicine, University of Ottawa.